Analysts expect over 2018 rising revenue Johnson & Johnson

Tomorrow Johnson & Johnson will publish it's past quarters results. For this year Johnson & Johnson's revenue will be around 81,38 billion USD. This is according to the average of the analysts' estimates. This is slightly more than 2017's revenue of 76,45 billion USD.

Historical revenues and results Johnson & Johnson plus estimates 2018

The analysts expect for 2018 a net profit of 22,27 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 8,16 USD. So the price/earnings-ratio equals 16,02.

For this year the analysts expect a dividend of 3,57 USD per share. Johnson & Johnson's dividend yield thus equals 2,73 percent. The average dividend yield of the health care companies equals a limited 1 percent.

Recent target prices around 135 USD

The most recent recommendations for the health care company are from Citigroup, Morgan Stanley and Independent Research.

Based on the current number of shares Johnson & Johnson's market capitalization equals 353,71 billion USD. The Johnson & Johnson stock was the past 12 months quite volatile. Since last January the stock is 9 percent lower. This year the stock price moved between 119 and 149 dollar. Since 2008 the stock price is almost 132 percent higher.

On Friday the stock closed at 130,69 USD.

Historical stock prices Johnson & Johnson from 2007 till 2018

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.